Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP5287.RAcPXDmcCG1HilBrLeakk85s0wZbfJwvB-M1noLd8eWQ8#assertion> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- assertion wasGeneratedBy ECO_0000203 provenance.
- assertion wasDerivedFrom BEFREE provenance.
- assertion SIO_000772 23911702 provenance.
- assertion evidence source_evidence_literature provenance.
- assertion description "[Compared to CD45-low patients, CD45-high patients had a lower event-free survival rate (B-cell-precursor acute lymphoblastic leukemia: 72 � 3% versus 86 � 1%, P<0.0001; T-cell acute lymphoblastic leukemia: 60 � 8% versus 78 � 4%, P=0.02), which was mainly attributable to a higher cumulative relapse incidence (B-cell-precursor acute lymphoblastic leukemia: 22 � 3% versus 11 � 1%, P<0.0001; T-cell acute lymphoblastic leukemia: 31 � 8% versus 11 � 3%, P=0.003) and kept its significance in multivariate analysis considering sex, age, initial white blood cell count, and minimal residual disease in B-cell-precursor- and T-cell acute lymphoblastic leukemia, and additionally presence of ETV6/RUNX1, MLL/AF4 and BCR/ABL1 rearrangements in B-cell-precursor acute lymphoblastic leukemia (P=0.002 and P=0.025, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.